We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
-5.85%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$35.2B
AUM Growth
-$3.94B
(-10%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$63.8M |
| 2 |
Align Technology
ALGN
|
+$61.4M |
| 3 |
Stellantis
STLA
|
+$54.4M |
| 4 |
UBS Group
UBS
|
+$49.7M |
| 5 |
Republic Services
RSG
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$73.1M |
| 2 |
IPG Photonics
IPGP
|
+$62.1M |
| 3 |
Adobe
ADBE
|
+$61.1M |
| 4 |
UnitedHealth
UNH
|
+$56.3M |
| 5 |
Apple
AAPL
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.86% |
| 2 | Healthcare | 17.08% |
| 3 | Financials | 11.33% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NYXH
701
Nyxoah
NYXH
$159M
| $3.56M | 0.01% |
186,200
+5,200
| +3% | +$105K |
|
702
Alpha Metallurgical Resources
AMR
$2.5B
| $3.52M | 0.01% |
26,700
+7,300
| +38% | +$670K |
|
703
Center Bancorp
CNOB
$1.6B
| $3.48M | 0.01% |
108,800
-4,000
| -4% | -$134K |
|
704
Itaú Unibanco
ITUB
$89.7B
| $3.47M | 0.01% |
+687,824
| New | +$2.9M |
|
705
MYR Group
MYRG
$4.3B
| $3.46M | 0.01% |
36,800
-1,200
| -3% | -$114K |
|
706
Pinnacle Financial Partners Inc
PNFP
$15.1B
| $3.44M | 0.01% |
37,400
+7,300
| +24% | +$721K |
|
707
Teladoc Health
TDOC
$1.19B
| $3.44M | 0.01% |
47,724
-6,301
| -12% | -$454K |
|
708
Corpay
CPAY
$26.7B
| $3.36M | 0.01% |
13,500
-16,800
| -55% | -$3.98M |
|
709
Camden Property Trust
CPT
$11.9B
| $3.36M | 0.01% |
+20,191
| New | +$3.33M |
|
710
Dentsply Sirona
XRAY
$2B
| $3.32M | 0.01% |
67,507
-281,600
| -81% | -$14.9M |
|
711
LKQ Corp
LKQ
$5.92B
| $3.29M | 0.01% |
72,404
-452,120
| -86% | -$23.1M |
|
712
Lockheed Martin
LMT
$123B
| $3.28M | 0.01% |
7,423
+400
| +6% | +$162K |
|
713
Brookfield Renewable
BEPC
$5.42B
| $3.27M | 0.01% |
74,700
-33,400
| -31% | -$1.23M |
|
714
NCR Voyix
VYX
$1.05B
| $3.25M | 0.01% |
131,867
-11,899
| -8% | -$292K |
|
|
CMA
715
DELISTED
Comerica
CMA
| $3.25M | 0.01% |
35,900
+9,900
| +38% | +$934K |
|
716
Tenet Healthcare
THC
$21.2B
| $3.21M | 0.01% |
+37,400
| New | +$3.07M |
|
|
NXRT
717
NexPoint Residential Trust
NXRT
$564M
| $3.21M | 0.01% |
35,500
+15,700
| +79% | +$1.31M |
|
718
World Kinect Corp
WKC
$1.82B
| $3.2M | 0.01% |
118,500
| – | – |
|
719
Ionis Pharmaceuticals
IONS
$7.8B
| $3.2M | 0.01% |
86,300
-1,600
| -2% | -$52.4K |
|
|
IPG
720
DELISTED
Interpublic Group of Companies
IPG
| $3.18M | 0.01% |
+89,698
| New | +$3.23M |
|
721
IDEAYA Biosciences
IDYA
$3.66B
| $3.16M | 0.01% |
282,104
+2
| +0% | +$29 |
|
722
Boeing
BA
$166B
| $3.15M | 0.01% |
16,445
-1,011
| -6% | -$203K |
|
723
Qfin Holdings
QFIN
$981M
| $3.13M | 0.01% |
203,500
-29,000
| -12% | -$542K |
|
724
Western Alliance Bancorporation
WAL
$8.64B
| $3.1M | 0.01% |
37,400
-124,337
| -77% | -$12.2M |
|
|
CTRA
725
DELISTED
Coterra Energy
CTRA
| $3.08M | 0.01% |
114,059
+89,332
| +361% | +$2.09M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2022 Portfolio in Review
As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Freshpet worth $30.3M.
- Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
- Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
- Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
- Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
- Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
- Axa opened 111 new positions and closed 94 in Q1 2022.
- Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.
Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.